These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29516319)

  • 21. XPC Polymorphism and Risk for Lung Cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes.
    Lawania S; Singh N; Behera D; Sharma S
    Pathol Oncol Res; 2018 Apr; 24(2):353-366. PubMed ID: 28540485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer.
    Vogel U; Overvad K; Wallin H; Tjønneland A; Nexø BA; Raaschou-Nielsen O
    Cancer Lett; 2005 May; 222(1):67-74. PubMed ID: 15837542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XPF polymorphism toward lung cancer susceptibility and survival in patients treated with platinum-based chemotherapy.
    Lawania S; Sharma S; Singh N; Behera D
    Future Oncol; 2018 May; 14(11):1071-1089. PubMed ID: 29741112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Investigation of Polymorphic OGG1 and MUTYH Genes Towards Increased Susceptibility in Lung Adenocarcinoma and its Impact on Overall Survival of Lung Cancer Patients Treated with Platinum Based Chemotherapy.
    Singh A; Singh N; Behera D; Sharma S
    Pathol Oncol Res; 2019 Oct; 25(4):1327-1340. PubMed ID: 29209987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XPA A23G polymorphism and risk of digestive system cancers: a meta-analysis.
    He L; Deng T; Luo H
    Onco Targets Ther; 2015; 8():385-94. PubMed ID: 25709470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the relationship between polymorphisms of XPA gene and susceptibility of esophageal cancer].
    Feng XX; Duan PF; Wang LB; Zhang JB; Lu ZX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):930-3. PubMed ID: 19173862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XPG polymorphisms and their association with lung cancer susceptibility, overall survival and response in North Indian patients treated with platinum-based doublet chemotherapy.
    Lawania S; Singh N; Behera D; Sharma S
    Future Oncol; 2019 Jan; 15(2):151-165. PubMed ID: 30522358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
    Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
    Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome.
    Santiago SP; Junior HLR; de Sousa JC; de Paula Borges D; de Oliveira RTG; Farias IR; Costa MB; Maia ARS; da Nóbrega Ito M; Magalhães SMM; Pinheiro RF
    Leuk Res; 2017 Jul; 58():73-82. PubMed ID: 28472728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer.
    Raaschou-Nielsen O; Sørensen M; Overvad K; Tjønneland A; Vogel U
    Lung Cancer; 2008 Feb; 59(2):171-9. PubMed ID: 17913280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the
    Wu L; Gao X; Ye D; Ding Y; Yang XI; Liu W
    Mol Clin Oncol; 2015 May; 3(3):649-654. PubMed ID: 26137282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.
    Gao C; Wang J; Li C; Zhang W; Liu G
    PLoS One; 2016; 11(9):e0160801. PubMed ID: 27622501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
    Kalikaki A; Kanaki M; Vassalou H; Souglakos J; Voutsina A; Georgoulias V; Mavroudis D
    Clin Lung Cancer; 2009 Mar; 10(2):118-23. PubMed ID: 19362955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN polymorphisms contribute to clinical outcomes of advanced lung adenocarcinoma patients treated with platinum-based chemotherapy.
    Yang Y; Xu W; Liu D; Ding X; Su B; Sun Y; Gao W
    Tumour Biol; 2016 Jun; 37(6):7785-96. PubMed ID: 26695147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional role of CyclinD1 polymorphism (G870A) in modifying susceptibility and overall survival of North Indian lung cancer patients.
    Pandey A; Bahl C; Sharma S; Singh N; Behera D
    Tumori; 2018 Jun; 104(3):179-187. PubMed ID: 30086699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia pathway genetic variants predict survival of non-small-cell lung cancer patients receiving platinum-based chemotherapy.
    Li R; Gu J; Heymach JV; Shu X; Zhao L; Han B; Ye Y; Roth J; Wu X
    Carcinogenesis; 2017 Apr; 38(4):419-424. PubMed ID: 28186269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.